MATEON THERAPEUTICS TEAM PUBLISHES A NEW PEER-REVIEWED ONCOLOGY ARTICLE ON THE POSITIVE CLINICAL STUDY RESULTS FOR OT-101 AGAINST RECALCITRANT RESISTANT ANAPLASTIC ASTROCYTOMA – A RARE FORM OF MALIGNANT BRAIN TUMOR

NEXT STORY
La Jolla Pharmaceutical Company to Provide GIAPREZA™ (Angiotensin II) for Named Patient Emergency Use in Patients with Septic Shock Due to COVID-19 at Guy’s and St. Thomas’ NHS Foundation Trust, London, United Kingdom
PREV STORY
Biomerica Signs Two Definitive Agreements with Mount Sinai Medical School in New York to Scale-up a Laboratory Version Serological Test for COVID-19 That Enables High-Volume Screenings in Labs
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Air Methods Supports Hurricane Relief Efforts

ENGLEWOOD, Colo., Sept. 14, 2017 (GLOBE NEWSWIRE) -- In a release issued under the ...

author_avatar
NASDAQ Market News

Meticore: Best Weight Loss Diet Pills or Cheap Fat Burner? 2021 Review by Health Supplement.net

author_avatar
NASDAQ Market News

Insights on the Electronic Skin Patches Global Market to 2031 – Players Profiled Include VitalConnect, Sensium Healthcare and Quad Industries Among Others

author_avatar
NASDAQ Market News